Whether in China or the United States, AstraZeneca's chief exec Pascal Soriot (pictured) knows how to capture headlines.

In today’s CEO Daily: Diane Brady talks to AstraZeneca CEO Pascal Soriot. The big story: Trump punishes the WSJ for its Epstein scoop. The markets: Low drama. Analyst notes from Deutsche Bank on ...

AstraZeneca made a big commitment to China as CEO Pascal Soriot joined British Prime Minister Keir Starmer on a trip to the ...

U.S. President Donald Trump speaks during an announcement about lowering U.S. drug prices next to Secretary of Commerce Howard Lutnick, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr ...

British pharmaceutical group AstraZeneca said Thursday that it would invest $15 billion in China through 2030 to expand its ...

By Andrew MacAskill and Maggie Fick BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca will invest $15 billion in ...

AstraZeneca CEO Pascal Soriot on Tuesday reiterated the pharmaceutical firm's commitment to the U.S. market amid reports that he is considering shifting its listing stateside. Stream Connecticut News ...

The “most favored nation” (MFN) drug pricing deal AstraZeneca recently signed with the Trump administration won’t affect the British pharma’s revenue target, CEO Pascal Soriot said. “We can absorb the ...

A view of a helmet with the AstraZeneca logo next to a bust of former U.S. President Abraham Lincoln on the day of an announcement about lowering U.S. drug prices, at the White House in Washington, ...